Table Of Contents:

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Treatment

  2.3.2 Market Size By Route of Administration

  2.3.3 Market Size By Type

  2.3.4 Market Size By Care Delivery Setting

 2.3.5 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1 Pharmaceutical Ingredients, Medical Equipment & Healthcare Technology Suppliers

3.4.2 Drug Addiction Treatment Providers & Pharmaceutical Companies

3.4.3 Rehabilitation Centers, Hospitals, Clinics & Healthcare Service Providers

3.4.4 Patients, Healthcare Providers, Government & Institutional End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Treatment Access & Patient Outcomes Statistics

  4.1.1 Share of Patients Receiving Evidence-Based Drug Addiction Treatment (%)

  4.1.2 Average Treatment Completion Rate Among Patients (%)

  4.1.3 Average Reduction in Substance Use Following Treatment (%)

  4.1.4 Share of Patients Achieving Sustained Recovery After Treatment (%)

  4.1.5 Average Reduction in Drug-Related Emergency Visits Following Treatment (%)

 4.2 Medication-Assisted Treatment & Clinical Care Metrics

  4.2.1 Share of Patients Receiving Medication-Assisted Treatment (%)

  4.2.2 Share of Treatment Facilities Offering Medication-Assisted Treatment Programs (%)

  4.2.3 Average Treatment Adherence Rate Among Medication-Assisted Therapy Patients (%)

  4.2.4 Average Reduction in Withdrawal Symptom Severity Through Pharmacological Treatment (%)

  4.2.5 Share of Patients Receiving Combined Medication and Behavioral Therapies (%)

 4.3 Rehabilitation & Behavioral Therapy Indicators

  4.3.1 Share of Patients Participating in Behavioral Therapy Programs (%)

  4.3.2 Average Improvement in Treatment Engagement Through Cognitive Behavioral Therapy (%)

  4.3.3 Share of Treatment Programs Offering Counseling and Psychosocial Support (%)

  4.3.4 Average Reduction in Treatment Dropout Rates Through Integrated Care (%)

  4.3.5 Share of Recovery Programs Providing Long-Term Aftercare Services (%)

 4.4 Treatment Facility & Service Delivery Statistics

  4.4.1 Share of Addiction Treatment Facilities Offering Inpatient Services (%)

  4.4.2 Share of Facilities Offering Outpatient Addiction Treatment Programs (%)

  4.4.3 Average Patient-to-Healthcare-Provider Ratio in Addiction Treatment Facilities

  4.4.4 Share of Treatment Facilities Providing Telehealth-Based Addiction Services (%)

  4.4.5 Average Treatment Waiting Time for Drug Addiction Services (Days)

5. Drug Addiction Treatment Market Segmental Analysis & Forecast, By Treatment, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Therapy

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Medications

 5.4 Rehabilitation Programs

 5.5 Others

6. Drug Addiction Treatment Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Oral

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Injectable

 6.4 Others

7. Drug Addiction Treatment Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Others

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Stimulant Addiction

 7.4 Nicotine/Tobacco

 7.5 Others

8. Drug Addiction Treatment Market Segmental Analysis & Forecast, By Care Delivery Setting, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Rehabilitation Centers

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Hospitals

 8.4 Outpatient Clinics

 8.5 Others

9. Drug Addiction Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2022–2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospital Pharmacies

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 Retail Pharmacies

  9.4 Online Pharmacies

10. Drug Addiction Treatment Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Drug Addiction Treatment Market Size & Forecast, By Treatment, 2022–2035

  10.2.3 Drug Addiction Treatment Market Size & Forecast, By Route of Administration, 2022–2035

  10.2.4 Drug Addiction Treatment Market Size & Forecast, By Type, 2022–2035

  10.2.5 Drug Addiction Treatment Market Size & Forecast, By Care Delivery Setting, 2022–2035

  10.2.6 Drug Addiction Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

  10.2.7 Drug Addiction Treatment Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Drug Addiction Treatment Market Size & Forecast, By Treatment, 2022–2035

 10.3.3 Drug Addiction Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.3.4 Drug Addiction Treatment Market Size & Forecast, By Type, 2022–2035

 10.3.5 Drug Addiction Treatment Market Size & Forecast, By Care Delivery Setting, 2022–2035

 10.3.6 Drug Addiction Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.3.7 Drug Addiction Treatment Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Drug Addiction Treatment Market Size & Forecast, By Treatment, 2022–2035

 10.4.3 Drug Addiction Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.4.4 Drug Addiction Treatment Market Size & Forecast, By Type, 2022–2035

 10.4.5 Drug Addiction Treatment Market Size & Forecast, By Care Delivery Setting, 2022–2035

 10.4.6 Drug Addiction Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.4.7 Drug Addiction Treatment Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Drug Addiction Treatment Market Size & Forecast, By Treatment, 2022–2035

 10.5.3 Drug Addiction Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.5.4 Drug Addiction Treatment Market Size & Forecast, By Type, 2022–2035

 10.5.5 Drug Addiction Treatment Market Size & Forecast, By Care Delivery Setting, 2022–2035

 10.5.6 Drug Addiction Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.5.7 Drug Addiction Treatment Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Drug Addiction Treatment Market Size & Forecast, By Treatment, 2022–2035

 10.6.3 Drug Addiction Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.6.4 Drug Addiction Treatment Market Size & Forecast, By Type, 2022–2035

 10.6.5 Drug Addiction Treatment Market Size & Forecast, By Care Delivery Setting, 2022–2035

 10.6.6 Drug Addiction Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.6.7 Drug Addiction Treatment Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 South Africa

  10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Year-Wise Strategies & Development, 2022 – 2026

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

11.6.1 Alkermes plc

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 Geographical Presence

  11.6.1.5 SWOT Analysis

11.6.2 Pfizer Inc.

11.6.3 Teva Pharmaceutical Industries Ltd.

11.6.4 Mallinckrodt Pharmaceuticals

11.6.5 Hikma Pharmaceuticals PLC

11.6.6 Otsuka Pharmaceutical Co., Ltd.

11.6.7 Novartis AG

11.6.8 Dr. Reddy’s Laboratories Ltd.

11.6.9 Cipla Limited

11.6.10 Viatris Inc.

11.6.11 Camurus AB

11.6.12 Orexo AB

11.6.13 Braeburn Inc.

11.6.14 Emergent BioSolutions Inc.

11.6.15 Acadia Healthcare Company, Inc.

11.6.16 Universal Health Services, Inc.

11.6.17 Hazelden Betty Ford Foundation

11.6.18 American Addiction Centers

11.6.19 Eleanor Health

11.6.20 Indivior PLC

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures